Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids

Clinical trial NCT01388764 · COMPLETED

Trial details

NCT number: NCT01388764
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dystrophinopathy Duchenne Muscular Dystrophy Becker's Muscular Dystrophy

Start date: 2012-01-01
Primary completion: 2012-05-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.